相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Published on: October 11, 2024

合成新的醇特权基作为布林聚合抑制剂,具有潜在的抗癌活性

Hamada Hashem¹, Abdelfattah Hassan^2,3, Walid M Abdelmagid⁴

¹Pharmaceutical Chemistry Department, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.

Pharmaceuticals (Basel, Switzerland)

|September 28, 2024

概括

新型 thiazole chalcones 通过抑制氨酸聚合,显示出强大的抗癌活性. 这些化合物表现出广泛的抗瘤作用和有利于潜在的化疗开发的类似药物特性.

科学领域:

药用化学医学化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

图布林聚合是抗癌药物开发的关键目标.
和醇衍生物是已知的生物活动的支架.
开发新型抑制剂以向结素的菌素结合部位是癌症研究的一个活跃领域.

研究的目的:

合成和评估基于 thiazole 的新型 chalcones 作为潜在的抗癌剂.
研究它们作为氨酸聚合抑制剂的作用机制.
评估它们的药物相似性和口服生物可用性的潜力.

主要方法:

在体外对各种人类癌症细胞系进行抗癌查.
图布林聚合抑制试验.
分子对接研究以向结素的菌素结合部位.
对药物动力学特性进行计算预测.

主要成果:

醇衍生物2a-2p表现出广泛的抗瘤活性,GI50值在1.55至2.95μM之间.
化合物2e显著抑制了素聚合 (IC50 = 7.78 μM),与康布列塔斯-A4 (IC50 = 4.93 μM) 相比.
分子对接证实了化合物2e,2g和2h的有效结合到氨酸的菌素结合部位.
计算分析预测了这些化合物的良好的口服生物利用率和药物相似性.

结论:

基于 thiazole 的新型 chalcones 通过抑制氨酸聚合,显示出显著的抗癌潜力.
化合物2e是作为化疗剂进一步开发的有希望的主要候选物.
已识别的化合物需要进一步研究它们的治疗疗效和安全性.

关键词:

这是一种抗癌药物.科尔希辛的结合部位提亚醇石英石英的使用方法素抑制剂的使用

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Destabilization of Microtubules

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...